BRCA1 and BRCA2 Mutations in Women of Different Ethnicities Undergoing Testing for Hereditary Breast-Ovarian CancerHALL, Michael J; REID, Julia E; BURBIDGE, Lynn A et al.Cancer. 2009, Vol 115, Num 10, pp 2222-2233, issn 0008-543X, 12 p.Article

Prediction of MLH1 and MSH2 mutations in lynch syndromeBALMANA, Judith; STOCKWELL, David H; BURBIDGE, Lynn Anne et al.JAMA, the journal of the American Medical Association. 2006, Vol 296, Num 12, pp 1469-1478, issn 0098-7484, 10 p.Article

Validation of a Cell-Cycle Progression Gene Panel to Improve Risk Stratification in a Contemporary Prostatectomy CohortCOOPERBERG, Matthew R; SIMKO, Jeffry P; CARROLL, Peter R et al.Journal of clinical oncology. 2013, Vol 31, Num 11, pp 1428-1434, issn 0732-183X, 7 p.Article

Hazard ratio in clinical trialsSPRUANCE, Spotswood L; REID, Julia E; GRACE, Michael et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 8, pp 2787-2792, issn 0066-4804, 6 p.Article

Clinical characteristics of individuals with germline Mutations in BRCA1 and BRCA2: Analysis of 10,000 individualsFRANK, Thomas S; DEFFENBAUGH, Amie M; CRITCHFIELD, Gregory C et al.Journal of clinical oncology. 2002, Vol 20, Num 6, pp 1480-1490, issn 0732-183XArticle